@article{4f7cdfdedafc4345bae1f110e7106f34,
title = "Transient thyrotoxicosis during nivolumab treatment",
abstract = "Two patients presented with transient thyrotoxicosis within 2-4 weeks after starting treatment with nivolumab. This thyrotoxicosis turned into hypothyroidism within 6-8 weeks. Temporary treatment with a beta blocker may be sufficient.",
keywords = "Checkpoint inhibition, thyrotoxicosis, thyroiditis, lung cancer, immune related adverse reactions, IMMUNE CHECKPOINT INHIBITORS, CELL LUNG-CANCER, ADVANCED MELANOMA, PEMBROLIZUMAB, TOXICITIES, DOCETAXEL",
author = "{van Kooten}, {M. J.} and {van den Berg}, G. and Glaudemans, {A. W. J. M.} and Hiltermann, {T. J. N.} and Groen, {H. J. M.} and A. Rutgers and Links, {T. P.}",
year = "2017",
month = jun,
language = "English",
volume = "75",
pages = "204--207",
journal = "The Netherlands Journal of Medicine",
issn = "0300-2977",
publisher = "van Zuiden Communications BV.",
number = "5",
}